Impending changes to cannabis regulations in Israel have been a subject of discussion and writing, indicating a significant expansion of the market in that jurisdiction upon implementation.
Initially scheduled for release by the year's end, the new regulations have faced a delay of 3 months due to the ongoing conflict in the region, as reported by the Israeli Ministry of Health.
Discussions which have highlighted changes to Germany's cannabis laws, aim to remove cannabis from the Narcotics list. Introducing new adjustments will likely significantly expand the medical cannabis market in the EU's most densely populated country.
These changes are expected to come into effect around March or April of 2024.
It's noteworthy that two of the largest medicinal cannabis import markets globally are poised for exponential expansion around the same time frame.
Considering the significant market growth occurring in Australia, the anticipated regulatory changes in Israel and Germany bode well for companies involved in the global supply chain for medical cannabis, as well as domestic licensed cannabis producers in the three identified markets.
